- Home
- PRFX vs BBLG Comparison
PRFX vs BBLG Comparison
Compare PRFX & BBLG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PRFX | BBLG |
|---|---|---|
| Founded | 2007 | 2004 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Specialties |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.7M | 2.6M |
| IPO Year | 2020 | N/A |
Fundamental Metrics
Financial Performance| Metric | PRFX | BBLG |
|---|---|---|
| Price | $2.81 | $1.30 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 227.6K | 17.2K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.58 | $0.57 |
| 52 Week High | $3.71 | $5.98 |
Technical Indicators
Market Signals| Indicator | PRFX | BBLG |
|---|---|---|
| Relative Strength Index (RSI) | 58.23 | 41.53 |
| Support Level | $1.28 | $1.11 |
| Resistance Level | $3.65 | $1.88 |
| Average True Range (ATR) | 0.41 | 0.08 |
| MACD | -0.08 | 0.01 |
| Stochastic Oscillator | 19.27 | 50.91 |
Price Performance
Historical ComparisonAbout PRFX PainReform Ltd.
PainReform Ltd is a clinical-stage specialty pharmaceutical company. It is focused on the reformulation of established therapeutics. The company's product PRF-110 is based on the local anesthetic ropivacaine, targeting the post-operative pain relief market. PRF-110 is an oil-based, viscous, clear solution that is deposited directly into the surgical wound bed before closure to provide localized and extended post-operative analgesia.
About BBLG Bone Biologics Corp
Bone Biologics Corp is a healthcare solutions provider based in the United States. As a biotechnology firm, it engages its efforts in developing therapeutics to aid bone regeneration. The company's portfolio comprises its lead product, NELL-1, which is a bone void filler. Bone Biologics' technology has applications in the surgical specialties of spinal, orthopedic, general orthopedic, plastic reconstruction, neurosurgery, interventional radiology, and sports medicine.